- Home
- VSEC vs CRNX Comparison
VSEC vs CRNX Comparison
Compare VSEC & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEC
- CRNX
- Stock Information
- Founded
- VSEC 1959
- CRNX 2008
- Country
- VSEC United States
- CRNX United States
- Employees
- VSEC N/A
- CRNX N/A
- Industry
- VSEC Military/Government/Technical
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- VSEC Consumer Discretionary
- CRNX Health Care
- Exchange
- VSEC Nasdaq
- CRNX Nasdaq
- Market Cap
- VSEC 3.2B
- CRNX 2.8B
- IPO Year
- VSEC N/A
- CRNX 2018
- Fundamental
- Price
- VSEC $162.40
- CRNX $30.61
- Analyst Decision
- VSEC Strong Buy
- CRNX Strong Buy
- Analyst Count
- VSEC 4
- CRNX 7
- Target Price
- VSEC $145.00
- CRNX $74.33
- AVG Volume (30 Days)
- VSEC 260.0K
- CRNX 1.0M
- Earning Date
- VSEC 07-30-2025
- CRNX 08-07-2025
- Dividend Yield
- VSEC 0.25%
- CRNX N/A
- EPS Growth
- VSEC 31.62
- CRNX N/A
- EPS
- VSEC 0.95
- CRNX N/A
- Revenue
- VSEC $1,253,105,000.00
- CRNX $1,392,000.00
- Revenue This Year
- VSEC $2.95
- CRNX $489.51
- Revenue Next Year
- VSEC $14.66
- CRNX $661.93
- P/E Ratio
- VSEC $170.05
- CRNX N/A
- Revenue Growth
- VSEC 52.47
- CRNX 0.51
- 52 Week Low
- VSEC $80.60
- CRNX $24.10
- 52 Week High
- VSEC $169.00
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- VSEC 58.57
- CRNX 56.46
- Support Level
- VSEC $163.57
- CRNX $28.73
- Resistance Level
- VSEC $167.58
- CRNX $31.45
- Average True Range (ATR)
- VSEC 5.30
- CRNX 1.16
- MACD
- VSEC -0.92
- CRNX 0.25
- Stochastic Oscillator
- VSEC 53.75
- CRNX 86.34
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.